"Our products are built from our proprietary genetic databases, which are used to identify diagnostic and prognostic biomarkers for cancer.
Our intellectual property covers the areas of bladder, gastric, colorectal and endometrial cancers and melanoma; however, our commercial focus is on bladder cancer products for the short to medium term. Our wider portfolio is expected to provide us with further options in the future."
- Forums
- NZX - By Stock
- Ann: GENERAL: PEB: Pacific Edge Notified of Positive LCD Decision in USA
PEB
pacific edge limited
Add to My Watchlist
0.00%
!
10.5¢

"Our products are built from our proprietary genetic databases,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online